AB0460 INTERLEUKIN-6 INHIBITION WITH TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN PATIENTS WITH SERIOUS COMORBIDITIES
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.2179
Abstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related inflammatory conditions affecting people aged over 50 years.We present our experience of using tocilizumab (TCZ) therapy for management of GCA/PMR aggravated by severe concurrent… read more here.
Keywords: cell arteritis; giant cell; treatment; gca pmr ... See more keywords
AB0046 NO EVIDENCE FOR DISTURBED TH1 AND TH17 FREQUENCIES IN GCA AND PMR PATIENTS - A STUDY IN THE GRONINGEN GPS COHORT
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.4499
Abstract: Giant cell arteritis (GCA) is an aging-associated inflammatory disease of the large-sized arteries. GCA clinically and pathogenically overlaps with polymyalgia rheumatica (PMR), which affects the shoulders and hips. In the inflamed tissues, infiltrated CD4+ T-cells… read more here.
Keywords: pmr patients; th1 th17; cell; gca pmr ... See more keywords
OP0066 METABOLIC PROFILE AND COMORBIDITIES IN GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA PATIENTS BEFORE AND AFTER TREATMENT
Sign Up to like & getrecommendations! Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.2425
Abstract: Giant cell arteritis (GCA) is a granulomatous vasculitis that affects the large vessels, occurring in people over 50 years of age. GCA frequently overlaps with polymyalgia rheumatica (PMR), which affects the proximal joints in the… read more here.
Keywords: gca pmr; cohort; treatment; pmr patients ... See more keywords
Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
Sign Up to like & getrecommendations! Published in 2023 at "RMD Open"
DOI: 10.1136/rmdopen-2022-002640
Abstract: Objectives Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are age-associated inflammatory diseases that frequently overlap. Both diseases require long-term treatment with glucocorticoids (GCs), often associated with comorbidities. Previous population-based cohort studies reported that an… read more here.
Keywords: metabolic features; patients gca; gca pmr; giant cell ... See more keywords
Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.902155
Abstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated inflammatory diseases affecting patients above 50 years of age. Patients with GCA suffer from granulomatous inflammation of medium- to large-sized arteries. This inflammation can… read more here.
Keywords: gca; pet; gca pmr; giant cell ... See more keywords